ANGO Common Stock · Transaction Oct 20, 2025 · Filed Oct 24, 2025 · Amount pending receipt enrichment
AngioDynamics Inc
Veridion Score
BETAMEDIUM CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ANGO moving today?
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ANGO overview
Related filings and maps
Congress activity in ANGO
ANGO · Transaction Jul 16, 2025 · Filed Jul 25, 2025 · $1,001 to $15,000
AngioDynamics, Inc. - Common Stock · Transaction Jun 27, 2025 · Filed Jul 25, 2025 · $1,001 to $15,000
ANGO Common Stock · Transaction Nov 8, 2016 · Filed Dec 25, 2016 · Amount pending receipt enrichment
ANGO Common Stock · Transaction Apr 27, 2016 · Filed Jul 6, 2016 · Amount pending receipt enrichment
ANGO contract awards, year to date.
Public federal awards linked to this ticker.
ANGO lobbying filings, year to date.
Registered lobbying filings matched to AngioDynamics Inc.